6th Cir.

United States v. Hamaed

June 12, 2026 ·25-1104 ·Published ·Circuit Judge Mathis · By Aisha Johnson

The Sixth Circuit affirmed the convictions of five pharmacists for a healthcare fraud scheme involving billing for prescriptions never dispensed. The court rejected challenges to the admission of expert testimony and the exclusion of evidence regarding legitimate billing practices.

Listen to this decision 0:00 / 1:36

Background

Five pharmacists operating pharmacies in Michigan and Ohio engaged in a scheme to bill insurers for prescriptions they did not dispense. They targeted patients who did not pick up medications, forged signatures, and replaced brand-name drugs with generics to pocket insurance payments. Qlarant, a government contractor, detected the fraud through invoice reviews, calculating a loss of over thirteen million dollars. A grand jury charged the defendants with conspiracy to commit healthcare and wire fraud. Four defendants went to trial and were convicted, while one pleaded guilty. The defendants appealed their convictions and sentences.

The court’s reasoning

The court held that the expert witness, Johanna Sullivan, did not violate the Confrontation Clause because she performed her own analysis and interpretation of the data rather than merely acting as a mouthpiece for non-testifying analysts. The court found that the district court properly excluded evidence of legitimate billing and PBM bias as confusing or marginally relevant. The court also determined that the evidence supported a single conspiracy charge despite the involvement of multiple pharmacies, as the defendants shared a common goal and used identical fraudulent methods. Finally, the court affirmed the sentences as reasonable.

What it means going forward

The decision clarifies that expert witnesses may rely on data processed by others provided they conduct their own independent analysis, reinforcing the admissibility of complex fraud evidence in healthcare cases.